Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world.

Background: Estimating patient attrition across lines of treatment (i.e. the probability that upon treatment failure the patient will not be able to receive a subsequent treatment) may be a valuable tool for optimizing treatment sequencing.